patient perspective on prior authorization
play

Patient Perspective on Prior Authorization Anna Hyde, Vice President - PowerPoint PPT Presentation

Patient Perspective on Prior Authorization Anna Hyde, Vice President of Advocacy and Access Arthritis Foundation Arthritis Patient Experience with PA The Issue AF survey shows prior auth as the top health care challenge every year


  1. Patient Perspective on Prior Authorization Anna Hyde, Vice President of Advocacy and Access Arthritis Foundation

  2. Arthritis Patient Experience with PA The Issue • AF survey shows prior auth as the top health care challenge every year • Contributes to overall administrative burden • 48% spend more than 5 hours a month managing health coverage, 17% spend more than 15 hours a month • Focus groups show across-the-board frustration at complexity of health system and constant policy changes without clear communication zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA The Impact Ac c e ss Issue s I mpa c ting Pe o ple with Arthritis 40% • Delays in treatment 34% 32% 32% 30% 29% 29% 28% • Stress and anxiety 28% 28% 26% 26% 24% 21% • In some cases abandoning therapy 16% • Administrative-driven decision making Prio r Cha ng e s to Hig h Hig h c o - Ste p the ra py a utho riza tio n drug fo rmula ry de d uc tib le insura nc e fo r (F a il first) me dic a tio ns 2017 2018 2019

  3. In their own words “Our daughte r was diagnose d with juve nile ar thr itis. “My physic ian de c ide d the biologic me dic ation I We ’ve had diffic ulty ge tting thr ough insur anc e pr ior was on was not wor king. It took ove r six we e ks author izations for c hange s in biologic s and have also be for e a ne w biologic was appr ove d. T he pain had to de al with ste p the r apy. T he r e ar e de finite ly le ve l r e quir e d I r e tur n to pr e dnisone , whic h c ause s things we c hoose not to do as a family be c ause of othe r issue s, suc h as we ight gain, thinning of the time and c osts of me dic al e xpe nse s.” bone s, inte r r upte d sle e p and highe r blood gluc ose le ve ls. I e nde d up ne e ding a painful pr oc e dur e to r e duc e the buildup of fluid in my kne e . I c an’t he lp but think if I had gotte n the ne w me dic ation appr ove d soone r , I would have be e n able to “I have RA and PsA. E ve r y time my body de c ide s that avoid this painful pr oc e dur e .” a c e r tain me dic ine will no longe r wor k, the r e is a wait for pr ior author ization and the n I usually have to take one day to c onne c t my r he umatologist, the phar mac y, and my insur e r to str aighte n it out.”

  4. zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA Our Policy Position on Prior Authorization The Arthritis Foundation worked with the American Medical Association and other provider groups to establish twenty-one prior authorization principles, including: • Establish a single, standardized form for physicians to submit prior authorization requests • Establish electronic systems for the submission of prior authorization requests • Require prior authorization requests to be completed by insurers within 48 hours of submission or receive automatic approval • Once approved, permit authorizations to remain in place for up to 12 months for people with chronic conditions, such as rheumatoid arthritis (RA) • If a prior authorization request is denied, the member must be given clear instructions on how to file an appeal, the information required and deadlines • Provide a process for expedited appeals, especially for urgent care services • Health plans should offer providers/practices at least one physician-driven, clinically based alternative to prior authorization, such as but not limited to “gold-card” or “preferred provider” programs or attestation of use of appropriate use criteria, clinical decision support systems or clinical pathways

  5. What Patients Want • Streamlined process with online tracking capability • Online portal to file and manage claims; would reduce admin burden for patients and providers • Faster response times, especially for drugs the patient is already taking • Transparency about the process from the beginning all the way through • 95% of survey respondents want to know which medications will require prior auth before its prescribed • 75% of survey respondents want transparency every step of the way, not just when approved or denied • Patients want relevant contact info and a step-by-step process on how to file an appeal • Clear, reasonable explanations for denials A.

Recommend


More recommend